| Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses N Ortega, M Ribes, M Vidal, R Rubio, R Aguilar, S Williams, D Barrios, ... Nature Communications 12 (1), 1-10, 2021 | 122* | 2021 |
| Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity J Carrillo, N Izquierdo-Useros, C Ávila-Nieto, E Pradenas, B Clotet, ... Biochemical and Biophysical Research Communications 538, 187-191, 2021 | 113 | 2021 |
| Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes E Pradenas, B Trinité, V Urrea, S Marfil, C Ávila-Nieto, ... Med, 2021 | 107 | 2021 |
| SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity B Trinité, F Tarrés-Freixas, J Rodon, E Pradenas, V Urrea, S Marfil, ... Scientific Reports 11 (1), 2608, 2021 | 97 | 2021 |
| Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro J Munoz-Basagoiti, D Perez-Zsolt, R Leon, V Blanc, D Raich-Regue, ... Journal of Dental Research 100 (11), 1265-1272, 2021 | 78 | 2021 |
| High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial A Alemany, P Millat-Martinez, M Corbacho-Monné, P Malchair, D Ouchi, ... The Lancet Respiratory Medicine 10 (3), 278-288, 2022 | 69 | 2022 |
| Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis … JM Díez, C Romero, M Cruz, P Vandeberg, WK Merritt, E Pradenas, ... The Journal of Infectious Diseases 225 (6), 938-946, 2022 | 30* | 2022 |
| Clinical course impacts early kinetics,magnitude and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection E Pradenas, B Trinité, V Urrea, S Marfil, F Tarrés-Freixas, R Ortiz, ... Cell Reports Medicine, 100523, 2022 | 28* | 2022 |
| Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients P Millat-Martinez, A Gharbharan, A Alemany, C Rokx, C Geurtsvankessel, ... Nature Communications 13 (1), 1-9, 2022 | 22 | 2022 |
| Previous SARS-CoV-2 infection increases B.1.1.7 cross-neutralization by vaccinated individuals B Trinité, E Pradenas, S Marfil, C Rovirosa, V Urrea, F Tarrés-Freixas, ... Viruses 13 (6), 1135, 2021 | 22 | 2021 |
| First Detection of SARS-CoV-2 Delta (B. 1.617. 2) Variant of Concern in a Dog with Clinical Signs in Spain L Fernández-Bastit, J Rodon, E Pradenas, S Marfil, B Trinité, M Parera, ... Viruses 13 (12), 2526, 2021 | 21 | 2021 |
| Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre … J Corominas, C Garriga, A Prenafeta, A Moros, M Cañete, A Barreiro, ... The Lancet Regional Health–Europe, 2022 | 18 | 2022 |
| Performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests for Omicron and other variants of concern D Raïch-Regué, J Muñoz-Basagoiti, D Perez-Zsolt, M Noguera-Julian, ... Frontiers in Microbiology 13, 810576, 2022 | 18 | 2022 |
| Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 A Barreiro, A Prenafeta, G Bech-Sabat, M Roca, EP Mur, R March, ... iScience, 2023 | 13* | 2023 |
| Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities M Trigueros, E Pradenas, D Palacín, F Muñoz-López, C Ávila-Nieto, ... Age and Ageing 51 (5), afac101, 2022 | 13* | 2022 |
| An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses F Tarrés-Freixas, C Aguilar-Gurrieri, ML Rodríguez de la Concepción, ... npj Vaccines 8 (1), 51, 2023 | 12 | 2023 |
| Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients S Garcia-Cirera, J Calvet, A Berenguer-Llergo, E Pradenas, S Marfil, ... Scientific Reports 12 (1), 1-9, 2022 | 11 | 2022 |
| Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report M Massanella, A Martin-Urda, L Mateu, T Marín, I Aldas, E Riveira-Muñoz, ... Open Forum Infectious Diseases 8 (7), ofab329, 2021 | 10 | 2021 |
| Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2 J Muñoz-Basagoiti, FLL Monteiro, LRH Krumpe, V Armario-Najera, ... Proceedings of the National Academy of Sciences 120 (10), e2214561120, 2023 | 8 | 2023 |
| Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals. E Ainsua-Enrich, N Pedreño-Lopez, C Bracke, C Avila-Nieto, ... iScience, 105455, 2022 | 8 | 2022 |
Julià BlancoIGTP, IRSICAIXA, UAB, UVIC-UCCVerified email at irsicaixa.es
